More than 3 billion people worldwide lived with a neurological condition in 2021, new study reports

Researchers estimated global, regional, and national health loss due to 37 nervous system conditions and their associated risk factors from 1990 to 2021.

AstraZeneca leans into GLP-1; Cuts looming at Bayer; Eli Lilly’s obesity approval; Endpoints Slack interview with Matt Gline; and more

Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit

November 12, 2023

FDA-approved osteoporosis drug may treat rare genetic heart disease

A research team co-led by scientists at the University of Arizona College of Medicine – Tucson found that an osteoporosis drug might counter a rare

February 18, 2025

American Heart Association recognizes 2,671 health care organizations for commitment to cardiovascular patient care

The American Heart Association, a relentless force for a world of longer, healthier lives, has recognized 2,671 health care and emergency response organizations -; nearly

August 2, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.